$18.79▾ 4.08%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$19.61MTTM operating cash
Pre-profit
It generates operating cash even though it has no reported profit yet.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+5.5%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Fairly valued
Trading right around our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
Tandem Diabetes Care, Inc. is pre-profit. It generates operating cash even though it has no reported profit yet. Revenue is growing at a steady pace.
Key numbers
Valuation
EPS (TTM)$-1.40
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-9.2%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$1.03B
TTM (trailing 12 months, through fiscal Q1 FY2026)
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.